IP Library Granted Patent US 10,875,993
Granted Patent B2
US 10,875,993 · App. 16/641,945 · Granted Dec 29, 2020

Polypropylene composition

Inventors: Markus Gahleitner (Linz, AT); Jingbo Wang (Linz, AT); Klaus Bernreitner (Linz, AT); Peter Niedersuss (Linz, AT)
C08L23/12C08L2205/025C08L2205/035C08L2207/02C08L2314/02C08L2314/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,875,993
App. No.
16/641,945
Granted
Dec 29, 2020
Kind
B2
Abstract

New polypropylene composition which provides an excellent balance between mechanical properties, optical behaviour and low amounts of extractable substances combined with good retortability.

Claims (26)

1. A polypropylene composition comprising a blend of:

(A) 85.0 to 95.0 wt. % of a heterophasic propylene copolymer (HECO) comprising:

(A-1) 80.0 to 90.0 wt. % of a matrix (M) that is a propylene homopolymer (H-PP) with an MFR 2 (230° C., 2.16 kg, ISO1133) of from 0.8-10.0 g/10 min and

(A-2) 10.0 to 20.0 wt. % of an elastomeric propylene copolymer (EPC) dispersed in said matrix (M),

wherein said heterophasic propylene copolymer has a xylene cold soluble (XCS) fraction having a C2 content of from 15.0 to 30.0 wt. % and an intrinsic viscosity (IV; determined according to DIN ISO 1628/1 in decalin at 135° C.) of from 1.2 to 2.6 dl/g;

(B) 5.0 to 15.0 wt. % of a propylene-hexene random copolymer with a hexene content in the range of from 2.0 to 10.0 wt. % and an MFR 2 (230° C., 2.16 kg, ISO1133) in a range of from 1.0 to 20.0 g/10 min; and

(C) optionally an alpha nucleating agent.

2. The polypropylene composition according to claim 1 , wherein the composition has a total hexene content of from 0.1 to 1.5 wt. % and an MFR 2 (230° C., 2.16 kg, ISO1133) of from 1.0 to 15.0 g/10 min.

3. The polypropylene composition according to claim 1 , wherein the composition has a hexane soluble value (C6FDA) of ≤3.0 wt. %.

4. The polypropylene composition according to claim 1 , wherein the composition has a total hexene content of from 0.1 to 1.5 wt. % and a total ethylene content of from 1.5 to 6.2 wt. %.

5. The polypropylene composition according to claim 1 , wherein the composition has:

(i) a Flexural Modulus according to ISO 178 in a range of from 1000 to 1800 MPa,

(ii) a Charpy notched impact strength NIS +23° C. according to ISO 179 in the range of from 25 to 75 kJ/m 2 , and

iii) a Charpy notched impact strength NIS −20° C. according to ISO 179 1eA in the range of from 1.5 to 5.0 kJ/m 2 .

6. A polypropylene composition according to claim 1 , wherein the composition has a haze according to ASTM D 1003-00 measured on a 1 mm thick injection molded specimen of ≤50.0%.

7. A process for the preparation of the polypropylene composition according to claim 1 , the process comprising the steps of;

(i) preparing a heterophasic propylene copolymer (HECO) (A) in the presence of a Ziegler-Natta catalyst;

(ii) preparing a propylene-hexene random copolymer (B) by polymerizing propylene and hexene in the presence of a single site catalyst;

(iii) mixing said heterophasic propylene copolymer (HECO) (A) with the propylene-hexene random copolymer (B) to obtain a mixture of (A) and (B); and

(iv) extruding said mixture to obtain the blend of (A) and (B).

8. An article comprising the polypropylene composition according to claim 1 or the polypropylene composition prepared by the process according to claim 7 .

9. The article according to claim 8 , wherein the article is an unoriented film comprising more than 90% of the blend according to claim 1 or the blend prepared by the process according to claim 7 , wherein the film is a cast film or a blown film.

10. The article according to claim 9 , wherein the film has been subjected to a sterilization treatment.

11. The article according to claim 9 , wherein the film a) before sterilization treatment has a haze (b.s.) determined on 50 μm cast film of below 10.0% and b) after sterilization treatment at 121° C. for 30 min has a haze (a.s.) value determined on 50 μm cast film of below 15.0.

12. The article according to claim 11 , wherein the film has a Δ(haze) value, defined as Δ(haze)=(haze(a.s.)−haze(b.s.))/haze(b.s.)*100%, of below 10%.

13. The article according to claim 9 , wherein the film has a tensile modulus in machine (MD) direction determined according to ISO 527-3 on a 50 μm cast film in the range of from 750 to 1500 MPa.

Assignments (2)
CHANGE OF ADDRESS Recorded Feb 23, 2022
From: BOREALIS AG
To: BOREALIS AG
Reel/Frame 059219/0949 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2020
From: GAHLEITNER, MARKUS; WANG, JINGBO; BERNREITNER, KLAUS; NIEDERSUSS, PETER
To: BOREALIS AG
Reel/Frame 053514/0995 →
Cited By (4)
US 12,319,772 US 12,391,774 US 12,509,577 US 12,703,791